VUKOTIC, Ranka
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.480
AS - Asia 1.370
EU - Europa 1.331
SA - Sud America 196
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 6.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.441
SG - Singapore 467
CN - Cina 365
PL - Polonia 321
HK - Hong Kong 272
GB - Regno Unito 270
SE - Svezia 192
BR - Brasile 152
IT - Italia 111
VN - Vietnam 100
RU - Federazione Russa 97
DE - Germania 93
FI - Finlandia 62
BG - Bulgaria 38
UA - Ucraina 30
ID - Indonesia 24
TR - Turchia 24
JP - Giappone 21
AR - Argentina 20
CA - Canada 19
NL - Olanda 19
IN - India 17
ZA - Sudafrica 17
FR - Francia 15
KR - Corea 15
CZ - Repubblica Ceca 14
AT - Austria 13
MX - Messico 11
BD - Bangladesh 10
ES - Italia 10
LT - Lituania 10
AE - Emirati Arabi Uniti 7
MA - Marocco 7
EG - Egitto 6
IQ - Iraq 6
RO - Romania 6
BE - Belgio 5
IL - Israele 5
PK - Pakistan 5
CH - Svizzera 4
CO - Colombia 4
GR - Grecia 4
IE - Irlanda 4
MY - Malesia 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
JO - Giordania 3
KH - Cambogia 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AU - Australia 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
PH - Filippine 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
CD - Congo 1
CU - Cuba 1
CV - Capo Verde 1
DK - Danimarca 1
EC - Ecuador 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.423
Salva come PNG Salva come JPEG
Città #
Santa Clara 510
Ashburn 337
Singapore 321
Warsaw 316
Fairfield 313
Chandler 302
Hong Kong 269
Nyköping 157
Houston 155
Woodbridge 124
Wilmington 112
Cambridge 108
Southend 104
Seattle 97
London 95
Chicago 82
Los Angeles 80
Beijing 73
New York 59
Helsinki 57
San Diego 52
Hefei 51
Ann Arbor 49
Moscow 45
Dearborn 44
Salt Lake City 44
Princeton 41
Ho Chi Minh City 39
Sofia 38
Jacksonville 31
Council Bluffs 30
Modena 27
Shanghai 27
The Dalles 25
Hanoi 22
São Paulo 22
Jakarta 20
Tokyo 20
Buffalo 18
Jersey City 16
Redwood City 16
Frankfurt am Main 14
Tampa 14
Dallas 13
Izmir 13
Brno 12
Seoul 12
Brooklyn 11
Elk Grove Village 11
Bremen 10
Guangzhou 10
Johannesburg 10
Nanjing 10
Orem 10
Redondo Beach 10
Sterling 10
Belo Horizonte 9
Berlin 9
Falls Church 9
Grafing 9
Kilburn 9
San Jose 9
Toronto 9
Wuhan 9
Augusta 8
Bologna 8
Chiswick 8
Denver 8
Eugene 8
Vienna 8
Chennai 7
Groningen 7
Poplar 7
Cairo 6
Düsseldorf 6
Hounslow 6
Norwalk 6
Riverside 6
Rosario 6
West Jordan 6
Amsterdam 5
Atlanta 5
Brussels 5
Columbus 5
Decatur 5
Haiphong 5
Istanbul 5
Lancaster 5
Montreal 5
Munich 5
Newark 5
San Francisco 5
San Mateo 5
Athens 4
Baghdad 4
Boardman 4
Brasília 4
Campinas 4
Cuauhtémoc 4
Da Nang 4
Totale 4.794
Salva come PNG Salva come JPEG
Nome #
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 573
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 352
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 343
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 341
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 266
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 259
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 254
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 214
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 171
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 167
Clinical and serological profile of primary biliary cirrhosis in men 160
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 154
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 148
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 148
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 145
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 135
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 132
Familial intrahepatic cholestasis: New and wide perspectives 132
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 130
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 127
Bone marrow derived stem cells for the treatment of end-stage liver disease 127
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 123
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 123
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 117
Hepatitis B virus and immune response 116
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 116
Hepatitis C Virus Core Antigen (HCVAg): An affordable assay to monitor the efficacy of treatment in DAAs era 116
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 113
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 103
Insights into cancer severity from biomolecular interaction mechanisms 98
Impact of psychosocial status on liver transplant process 96
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 95
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 95
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 95
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 92
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 92
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 88
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 86
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 84
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 83
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 81
Totale 6.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.563
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021414 0 0 0 0 0 0 24 37 183 24 127 19
2021/2022726 58 30 40 40 16 51 23 87 83 77 123 98
2022/2023746 108 105 69 78 74 114 11 67 81 4 21 14
2023/2024455 21 25 27 70 102 21 43 47 5 6 21 67
2024/20251.530 47 12 4 121 353 241 67 121 171 102 118 173
2025/20261.823 188 63 165 322 535 547 3 0 0 0 0 0
Totale 6.490